Brain implants improving life quality Balanced News

Source: https://www.city-journal.org/article/journalisms-responsibility-to-inform-on-transgender-issues
Source: https://www.city-journal.org/article/journalisms-responsibility-to-inform-on-transgender-issues

Blackrock Neurotech successfully implants brain chips, improving life quality for depression and paralysis patients.  


Helium Summary: US-based Blackrock Neurotech has implanted brain chips in 50 people, offering potential improvements in life quality for those with depression and paralysis [medicalxpress.com].

These direct-brain brain-computer interface (BCI) implants allow users to control devices, like wheelchairs and robotic arms, by merely thinking, surpassing Elon Musk's Neuralink in implant development.


May 23, 2023




Perspectives

Pro-BCI


BCI implants potentially improve quality of life and independence for people with various conditions.

Cautionary


Safety, ethical, and long-term consequences of these implants need further scrutiny before widespread adoption.



Q&A


How do BCI implants work?

BCI implants read electrical signals from the brain, allowing users to control devices through thought [medicalxpress.com].

How is Blackrock Neurotech ahead of Neuralink?

Blackrock has successfully implanted chips in humans, while Neuralink is still seeking FDA approval for human trials [medicalxpress.com].



News Media Bias


The source presents both the potential benefits and concerns of using BCI implants, demonstrating a balanced approach to reporting on this new technology.



Context


BCI implants, such as those developed by Blackrock Neurotech and Neuralink, represent an emerging area of research and development aimed at improving the quality of life for individuals with various conditions.



Takeaway


While Blackrock Neurotech's brain chip implants show promise in enhancing life quality, further ethical and safety evaluations are necessary.



Potential Outcomes




1. Widespread adoption of BCI implants (60%)

2. Enhanced scrutiny and regulations around BCI implantation (80%)

3. Development of alternative solutions for patient care (40%).



Popular Stories


Multiple mass shootings, deaths

Multiple mass shootings in April-May 2023 prompt gun control debates and public calls for action.

Biden family foreign payment allegations

Biden family allegedly received over $10 million from foreign entities; legality not suggested.

DeSantis, Trump clash in Iowa

DeSantis indirectly challenges Trump at separate events in Iowa, highlighting rivalry for 2024 GOP nomination.





Read Deeper


    
News Over Time     Most recent
Brain chips improve quality of life Balanced News

Brain chips implanted in people to cure fatal ailments; know new technique of biotech firm - DNA India

technology

While Elon Musk and the Neuralink team are attempting to obtain FDA approval to test their Neuralink BCIs on humans and have them authorised for medical usage, US company have surpassed them and implanted 50 chips successfully into people's brains. The NeuroPort Array was developed by Blackrock Neurotech, a firm whose scientists are confident that it would significantly improve the quality of life for people with depression, paralysis, and other illnesses. The company wants to make it possible for people with the implant to steer robotic arms and powered wheelchairs by using their thoughts. According to Blackrock Neurotech co-founder Marcus Gerhardt, "We are the only company with direct-brain BCI implants in humans."

dnaindia.com     May 07, 2023

First healthy volunteer dosed in study of HER-096 for Parkinson's... - Parkinson's News Today

technology

The first healthy volunteer has been dosed in a clinical study that will test the safety and efficacy of Herantis Pharma’s HER-096 treatment candidate for Parkinson’s disease, the company announced in a press release.

parkinsonsnewstoday.com     Apr 21, 2023

Effects of qCON and qNOX-guided general anaesthesia management on patient opioid use and prognosis: a study protocol

tech

Introduction The adverse effects of general anaesthetic drugs (especially opioids) cannot be ignored. However, current nociceptive-monitoring techniques still lack consistency in guiding the use of opioids. This trial will study the demand for opioid use and patient prognosis in qCON and qNOX-guided general anaesthesia management. Methods and analysis This prospective, randomised, controlled trial will randomly recruit 124 patients undergoing general anaesthesia for non-cardiac surgery in equal numbers to either the qCON or BIS group. The qCON group will adjust intraoperative propofol and remifentanil dosage according to qCON and qNOX values, while the BIS group will adjust according to BIS values and haemodynamic fluctuations.

BMJ     May 03, 2023

Calgary researchers building one of 'key centres in the world' for neurological disorder therapies, tech - Calgary Herald

health

A new network of health researchers and providers is working to introduce innovative therapies, clinical trials and technology for people with spinal cord injury, stroke and movement impairments.

calgaryherald.com     May 02, 2023

World's Smallest Implantable, Rechargeable Spinal Cord ...

More than 50 million people in the U.S. suffer from chronic pain. According to the U.S. Pain Foundation, chronic pain is the leading cause of people going to the doctor and costs the nation approximately USD 635 billion each year in healthcare, disability and lost productivity costs. Spinal cord stimulation (SCS), also known as neurostimulation, has been recommended by doctors for more than 50 years to help people manage chronic pain and improve their quality of life. Devices used for SCS consist of thin wires placed between the spinal cord and the vertebrae and a small implant placed under the skin in the lower back that helps disrupt pain signals before they can reach the brain.

hospimedica.com     Dec 28, 2022